Literature DB >> 20188349

Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons.

Anat Biegon1, Sung-Won Kim, Jean Logan, Jacob M Hooker, Lisa Muench, Joanna S Fowler.   

Abstract

BACKGROUND: Cigarette smoking and nicotine have complex effects on human physiology and behavior, including some effects similar to those elicited by inhibition of aromatase, the last enzyme in estrogen biosynthesis. We report the first in vivo primate study to determine whether there is a direct effect of nicotine administration on brain aromatase.
METHODS: Brain aromatase availability was examined with positron emission tomography and the selective aromatase inhibitor [(11)C]vorozole in six baboons before and after exposure to IV nicotine at .015 and .03 mg/kg.
RESULTS: Nicotine administration produced significant, dose-dependent reductions in [(11)C]vorozole binding. The amygdala and preoptic area showed the largest reductions. Plasma levels of nicotine and its major metabolite cotinine were similar to those found in cigarette smokers.
CONCLUSIONS: Nicotine interacts in vivo with primate brain aromatase in regions involved in mood, aggression, and sexual behavior. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188349      PMCID: PMC2904480          DOI: 10.1016/j.biopsych.2010.01.004

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

1.  Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields.

Authors:  M A Russell; C Wilson; U A Patel; C Feyerabend; P V Cole
Journal:  Br Med J       Date:  1975-05-24

Review 2.  A review of graphical methods for tracer studies and strategies to reduce bias.

Authors:  Jean Logan
Journal:  Nucl Med Biol       Date:  2003-11       Impact factor: 2.408

3.  Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats.

Authors:  D E Dluzen; L I Anderson
Journal:  Neurosci Lett       Date:  1997-07-18       Impact factor: 3.046

4.  Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine.

Authors:  P A Crooks; M Li; L P Dwoskin
Journal:  Drug Metab Dispos       Date:  1997-01       Impact factor: 3.922

5.  Osteoporosis and smoking.

Authors:  H W Daniell
Journal:  JAMA       Date:  1972-07-31       Impact factor: 56.272

Review 6.  Sex differences in nicotine effects and self-administration: review of human and animal evidence.

Authors:  K A Perkins; E Donny; A R Caggiula
Journal:  Nicotine Tob Res       Date:  1999-12       Impact factor: 4.244

7.  Synthesis, in vivo rhesus monkey biodistribution and in vitro evaluation of a 11C-labelled potent aromatase inhibitor: [N-methyl-11C]vorozole.

Authors:  P Lidström; T A Bonasera; D Kirilovas; B Lindblom; L Lu; E Bergström; M Bergström; J E Westlin; B Långström
Journal:  Nucl Med Biol       Date:  1998-07       Impact factor: 2.408

8.  Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase.

Authors:  Sung Won Kim; Anat Biegon; Zachary E Katsamanis; Carolin W Ehrlich; Jacob M Hooker; Colleen Shea; Lisa Muench; Youwen Xu; Payton King; Pauline Carter; David L Alexoff; Joanna S Fowler
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

Review 9.  Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.

Authors:  N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2008-02-27       Impact factor: 6.875

10.  Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.

Authors:  R L Barbieri; J Gochberg; K J Ryan
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more
  17 in total

1.  Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.

Authors:  Mark Weiser; Linda Levi; Daisy Zamora; Anat Biegon; John Paul SanGiovanni; Michael Davidson; Shimon Burshtein; Ilan Gonen; Paull Radu; Kristina Slobozean Pavalache; Igor Nastas; Rina Hemi; Timothy Ryan; John M Davis
Journal:  JAMA Psychiatry       Date:  2019-10-01       Impact factor: 21.596

2.  PET radiopharmaceuticals for probing enzymes in the brain.

Authors:  Jason P Holland; Paul Cumming; Neil Vasdev
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

3.  Unique distribution of aromatase in the human brain: in vivo studies with PET and [N-methyl-11C]vorozole.

Authors:  Anat Biegon; Sung Won Kim; David L Alexoff; Millard Jayne; Pauline Carter; Barbara Hubbard; Payton King; Jean Logan; Lisa Muench; Deborah Pareto; David Schlyer; Colleen Shea; Frank Telang; Gene-Jack Wang; Youwen Xu; Joanna S Fowler
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

Review 4.  Brain-derived estrogen and neural function.

Authors:  Darrell W Brann; Yujiao Lu; Jing Wang; Quanguang Zhang; Roshni Thakkar; Gangadhara R Sareddy; Uday P Pratap; Rajeshwar R Tekmal; Ratna K Vadlamudi
Journal:  Neurosci Biobehav Rev       Date:  2021-11-22       Impact factor: 8.989

Review 5.  In vivo visualization of aromatase in animals and humans.

Authors:  Anat Biegon
Journal:  Front Neuroendocrinol       Date:  2015-10-09       Impact factor: 8.606

Review 6.  Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment.

Authors:  Rebecca L Ashare; Mary Falcone; Caryn Lerman
Journal:  Neuropharmacology       Date:  2013-04-29       Impact factor: 5.250

7.  Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain.

Authors:  Anat Biegon; Nelly Alia-Klein; Joanna S Fowler
Journal:  Front Pharmacol       Date:  2012-11-06       Impact factor: 5.810

8.  CYP19A1 polymorphisms associated with coronary artery disease and circulating sex hormone levels in a Chinese population.

Authors:  Yajie Meng; Dilare Adi; Yun Wu; Yongtao Wang; Mayila Abudoukelimu; Ding Huang; Xiang Ma; Cheng Liu; Ting Wang; Fen Liu; Bangdang Chen; Mintao Gai; Xiaocui Chen; Zhenyan Fu; Yitong Ma
Journal:  Oncotarget       Date:  2017-10-07

9.  Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer.

Authors:  Anat Biegon; Kenneth R Shroyer; Dinko Franceschi; Jasbeer Dhawan; Mouna Tahmi; Deborah Pareto; Patrick Bonilla; Krystal Airola; Jules Cohen
Journal:  J Nucl Med       Date:  2019-11-22       Impact factor: 11.082

10.  Determining the IC 50 Values for Vorozole and Letrozole, on a Series of Human Liver Cytochrome P450s, to Help Determine the Binding Site of Vorozole in the Liver.

Authors:  Lendelle Raymond; Nikita Rayani; Grace Polson; Kylie Sikorski; Ailin Lian; Melissa A VanAlstine-Parris
Journal:  Enzyme Res       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.